President & CEO
Thu, Dec 18, 2025
Dec 18
28,400 shares @ $15.29
Increased holdings by +8.40%
15th largest trade (out of 67)
Positive 90D History
Trade made by an officer
67% win rate · +8.5% median edge vs SPY (18 trades, 90-day · small sample)
Insider trade was 66% below market price
Price 28% above 200-day moving average
CRNXCrinetics Pharmaceuticals, Inc.
Health CarePharmaceuticals
1D0.00%
1W+15.07%
1M+28.28%
3M+12.02%
6M—
1Y—